
Beijing
Martha regularly represents Chinese and international clients in cross-border M&A, private equity investments and financings, joint ventures, foreign direct investments and other compliance matters.
She has represented clients from a broad range of industries, including TMT, financial services, healthcare, consumer products, energy, manufacturing, etc.
In addition, she has experience in handling initial public offerings, debt and equity securities offerings, pre-IPO investments, as well as advising on restructuring, employment, antitrust, and general corporate matters.Beijing; New York
Xiang is a Guiding Expert of the China Overseas IP Dispute Response & Guidance Center.
He also serves several consultancy roles for local regulatory authorities, including as IP Guiding Expert of Shenzhen IP Protection Center; IP Guiding Expert of Zhejiang Province IP Protection Center; IP Consultant of Technology Innovation Bureau of Nanjing Jiangbei New Area Management Committee (Jiangsu Province); Expert of IP Dispute Investigation and Appraisal of Foshan Market Supervision and Administration Bureau (Guangdong Province); and Expert for Overseas IP Protection and Assistance of Foshan Intellectual Property Bureau (Guangdong Province).
Dr. Wang is an arbitrator of Beijing Arbitration Commission and Beijing International Arbitration Center.
Xiang has extensive experience in assisting local and foreign-based multinational companies with all aspects of their IP rights in the U.S. and China, including IP litigation and arbitration, patent infringement, industrial espionage, trade secret misappropriation, copyright and trademark infringement, ITC Sec. 337 investigations, patent office proceedings including inter partes reviews (IPR), IP due diligence and portfolio counseling, technology export control, mass torts and product liability, securities litigation, the Foreign Corrupt Practices Act (FCPA) and other investigations and compliance. These matters have implicated a vast array of technologies, from software and electronics to renewable energy and medical devices as well as agricultural and building materials, to name just a few.
Xiang also works extensively on cybersecurity investigations and data privacy compliance matters for both Chinese and international clients.
Xiang has been particularly active in Chinese state-owned enterprises related U.S. litigation. Clients turn to his strategic and innovative advice thanks to his in-depth understanding of their business needs and political risks. Clients appreciate that he “understood the environment in the China legal system and can give nuanced advice”.
Xiang has developed the region’s premier IP practice based on his reputation as one of the few IP lawyers who has a doctorate in electrical and computer engineering, a Juris Doctor, a Chinese Certificate of Laws, and admission to practice law in New York, Indiana and before the U.S. Patent and Trademark Office. Due to its success in patent disputes in the United States and China, involving both foreign and Chinese companies, Orrick IP team was exclusively featured in a documentary film “Patent Wars” by the China Central Television (CCTV).
Xiang is highly regarded for his practical legal advice that results from more than ten years of experience at medical and electronic device businesses before becoming a lawyer. He also has received four U.S. medical-technology patents in his name.
Beijing
Carol’s practice focuses on patent filing and prosecution, patent-related legal advice and patent litigation across a broad range of industries, including chemistry, materials science, pharmaceutical, biotechnology, medical device, semiconductor and auto mechanics. Carol has extensional experience in patent, trademark, domain name, copyright and trade secret.
Before joining Orrick, Carol worked with Lung Tin International Property Agent Ltd. and in Jones Day’s Beijing Office.
Beijing
Shelley's related IP experience includes the following:
Beijing; New York
Beijing; New York
Being recognized by Legal 500 Asia Pacific, Jeff has received clients’ praises as “an experienced lawyer, who understands the client’s business, both internally and externally", and his "understanding of the client’s business model, industry, customers and strategic objectives enables him to advise and guide clients on highly complex and sensitive matters”. Other clients comment that Jeff “develops the best strategies and solutions for clients” and “works very hard and is recognised by clients for his ability.” In addition, he is “dedicated to serving his clients and is able to leverage off the firm’s global network to provide services in specialized areas.” (Legal 500 Asia-Pacific, 2019 - 2023)
Jeff’s practice focuses on China-related inbound and outbound mergers and acquisitions and private equity transactions. He has extensive experience with share and asset acquisitions, growth capital and buyout transactions as well as tender offers, privatizations, restructurings, spin-offs, strategic alliances and joint ventures.
In addition, Jeff advises multinationals, financial institutions and private equity funds on their general corporate, capital markets and regulatory compliance matters.
Prior to joining Orrick, Jeff was a partner at the New York office of an international law firm. Earlier in his career, Jeff practiced in New York, Hong Kong, and mainland China with two major international law firms, and also served as the Head of Legal and Compliance of the U.S. operations of a leading Chinese investment bank, where he gained tremendous experience in helping Chinese clients navigate regulatory and compliance issues in the U.S.
Jeff serves on the International Advisory Board of Duke Law School, where he was also appointed as a Senior Lecturing Fellow. In his leisure time, Jeff serves on a volunteer basis as the Chief Legal Officer of The Chinese Finance Association (TCFA), a non-profit professional organization headquartered in New York with more than 7,000 members globally.